Dundas Minerals (ASX:DUN) tripled after ‘massive’ sulphides

Nick Sundich Nick Sundich, September 27, 2022

Despite the market crash this week, one which even the resources sector was caught up in, Dundas Minerals’ (ASX:DUN) shares have tripled this week. The gold and base metals explorer has rocketed after it published exploration results from its Albany-Fraser Orogen project in WA on Monday. But were the results really a big of a deal?

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

 

Dundas Minerals encounters ‘massive sulphides’

Dundas Minerals reported ‘massive sulphides’ from central target drill chips. Sounds good, doesn’t it? Especially when you consider that these results came from two different holes, that the drilling campaign was only just getting started and the company labelled these results ‘unexpected’. 

If only we new what “massive” means …

 

Dundas Minerals (ASX:DUN) share price chart (Graph: TradingView)

 

However, these results have only been analysed using a handheld portable XRF gun. These have not been checked off in a lab, although this will happen in the next 4 weeks.

Furthermore, results were susceptible to downhole smearing and formational contamination due to drilling techniques used as well as water saturation. 

 

This is good news, but early days

Although investors should be cautious, this is no doubt good news from Dundas Minerals. But there is still a long way to go for the company and more drilling to be undertaken. 

But as a company that listed late last year and spent much of this year underwater, shareholders have every right to be happy with its performance today.  

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY26

Recent Posts

ResMed (ASX:RMD) Crushes the Ozempic Fear Narrative with New Data: Is It Time to Buy?

ResMed data shows GLP-1 users use CPAP more ResMed (ASX: RMD) delivered another strong quarter, beating analyst expectations on both…

Champion Iron (ASX:CIA) Posts Record 3.9M Tonne Quarter as Green Steel Plant Enters Commissioning- Time to Buy?

Champion Iron’s Record Quarter Sets Up a Green Steel Catalyst Champion Iron (ASX: CIA) delivered record quarterly sales of 3.9…

6 ASX Stocks to Watch in February 2026: Uranium, Gold, Banks and Healthcare Lead the Way

February 2026 is shaping up as a pivotal month for ASX investors. Gold has smashed through $5,100 per ounce for…